Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).
Haemato AG (von First Berlin Equity Research GmbH) – Biotech Investments
Original-Research: Haemato AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Haemato AG Unternehmen: Haemato AG ISIN: DE000A289VV1